Cite
HARVARD Citation
Kwong, Y. et al. (2017). Low‐dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma. British journal of haematology. pp. 131-132. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kwong, Y. et al. (2017). Low‐dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma. British journal of haematology. pp. 131-132. [Online].